ACUR
ACUR clinical trials: ACURA PHARMACEUTICALS, INC
Every trial on ClinicalTrials.gov where ACURA PHARMACEUTICALS, INC is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 4
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
ACUR on the catalyst calendar · ACUR registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Feb 2010Actual | NCT01030406Study of the Relative Abuse Potential of Acurox Tablets in Non-Dependent Recreational Opioid UsersAcura Pharmaceuticals Inc. · Opioid Abuse | ACURLeadPFECollaborator | Phase 2 | Completed | Locked | Locked | Locked |
| Apr 2013Actual | NCT01759446Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid UsersAcura Pharmaceuticals Inc. · Opioid-Related Disorders | ACURLead | Phase 2 | Completed | Locked | Locked | Locked |
| Aug 2008Actual | NCT00699010Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid AbuseAcura Pharmaceuticals Inc. · Opioid Abuse | ACURLead | Phase 2 | Completed | Locked | Locked | Locked |
| Feb 2008Actual | NCT00654069Safety/Efficacy Study of Oxycodone HCl/Niacin to Treat Pain After BunionectomyAcura Pharmaceuticals Inc. · Pain | ACURLead | Phase 3 | Completed | Locked | Locked | Locked |
- Primary completion Feb 2010ActualPhase 2NCT01030406Study of the Relative Abuse Potential of Acurox Tablets in Non-Dependent Recreational Opioid UsersAcura Pharmaceuticals Inc. · Opioid AbuseCompletedACURLeadPFECollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2013ActualPhase 2NCT01759446Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid UsersAcura Pharmaceuticals Inc. · Opioid-Related DisordersCompletedACURLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2008ActualPhase 2NCT00699010Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid AbuseAcura Pharmaceuticals Inc. · Opioid AbuseCompletedACURLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2008ActualPhase 3NCT00654069Safety/Efficacy Study of Oxycodone HCl/Niacin to Treat Pain After BunionectomyAcura Pharmaceuticals Inc. · PainCompletedACURLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner